arctigenin has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Bakky, MS; Mohamadin, AM; Salama, SA | 1 |
| Li, A; Li, P; Shu, M; Wang, J; Wang, R; Wang, Y; Wu, M; Zhang, J; Zhang, X | 1 |
2 other study(ies) available for arctigenin and Kidney Diseases
| Article | Year |
|---|---|
Arctigenin alleviates cadmium-induced nephrotoxicity: Targeting endoplasmic reticulum stress, Nrf2 signaling, and the associated inflammatory response.
Topics: Animals; Cadmium; Endoplasmic Reticulum Stress; Furans; Inflammation Mediators; Kidney Diseases; Lignans; Male; NF-E2-Related Factor 2; Rats, Wistar | 2021 |
Arctigenin suppresses renal interstitial fibrosis in a rat model of obstructive nephropathy.
Topics: Animals; Chemokine CCL2; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Furans; Kidney; Kidney Diseases; Lignans; Lipid Peroxidation; Male; NF-kappa B; Oxidative Stress; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Ureteral Obstruction | 2017 |